BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1974850)

  • 1. A bidirectional regulatory network involving IL 2 and IL 4 in the alternative CD2 pathway of T cell activation.
    Lorré K; Van Damme J; Ceuppens JL
    Eur J Immunol; 1990 Jul; 20(7):1569-75. PubMed ID: 1974850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation.
    Lorré K; Van Damme J; Verwilghen J; Baroja ML; Ceuppens JL
    J Immunol; 1990 Jun; 144(12):4681-7. PubMed ID: 1972166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cell responses to IL-1 and IL-6 are dependent on signals mediated through CD2.
    Endler-Jobst B; Schraven B; Hutmacher B; Meuer SC
    J Immunol; 1991 Mar; 146(6):1736-42. PubMed ID: 1706379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
    Lorré K; Fransen L; Ceuppens JL
    Eur Cytokine Netw; 1992; 3(3):321-30. PubMed ID: 1353987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
    Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
    J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor requirements for activation and proliferation steps of human CD2+CD3-CD4-CD8- early thymocytes.
    Dalloul AH; Mossalayi MD; Dellagi K; Bertho JM; Debré P
    Eur J Immunol; 1989 Nov; 19(11):1985-90. PubMed ID: 2574677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells.
    Costello R; Cerdan C; Pavon C; Brailly H; Hurpin C; Mawas C; Olive D
    Eur J Immunol; 1993 Mar; 23(3):608-13. PubMed ID: 8095456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
    Costello R; Brailly H; Mallet F; Mawas C; Olive D
    Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.
    Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF
    J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
    Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
    Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 up-regulates its own production.
    Hu J; Vaquero C; Huet S; Bernard A; Sterkers G
    J Immunol; 1987 Dec; 139(12):4109-15. PubMed ID: 3121730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
    Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
    J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.
    Wasik MA; Morimoto C
    J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.
    Cerdan C; Martin Y; Courcoul M; Brailly H; Mawas C; Birg F; Olive D
    J Immunol; 1992 Oct; 149(7):2255-61. PubMed ID: 1356123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways.
    Cerdan C; Martin Y; Brailly H; Courcoul M; Flavetta S; Costello R; Mawas C; Birg F; Olive D
    J Immunol; 1991 Jan; 146(2):560-4. PubMed ID: 1670946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human lymphokine-activated killer effectors.
    Robinet E; Kamoun M; Farace F; Chouaib S
    Eur J Immunol; 1992 Nov; 22(11):2861-5. PubMed ID: 1358624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.